Skip to main content

Pancreatic Cancer Clinical Trials

Review the pancreatic cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 251-275 of 279

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients with a Known Family History of Pancreatic Cancer
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
A Psychosocial Oncology Intervention During Neoadjuvant Therapy for Patients with Localized Pancreatic Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Association between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-Cancer Patients
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients with Cancer
Status: Active
Location: Virginia K Crosson Cancer Center, Fullerton, California
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Status: Active
Location: 2 locations
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Status: Active
Location: See ClinicalTrials.gov
Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection
Status: Active
Location: 727 locations
Biomarker Analysis in Improving Screening in Patients with or at High Risk of Developing Pancreatic Cancer
Status: Active
Location: 9 locations
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Status: Active
Location: 202 locations
An Investigational Scan (Hyperpolarized Carbon-13 Pyruvate MRI) for Assessing Treatment Response in Patients with Locally Advanced or Metastatic Pancreatic Ductal Carcinoma
Status: Active
Location: University of California San Francisco, San Francisco, California
Association of Genomic Polymorphisms with Cancer Cachexia in Subjects with Pancreatic Adenocarcinoma
Status: Active
Location: Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina
Association of Plant-based Diet and Gut Microbiome Signature with Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Pancreatic Cancer Early Detection Consortium
Status: Active
Location: 23 locations
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Status: Active
Location: 11 locations
Biomarkers for the Early Detection, Surveillance, and Monitoring in Patients with Locally Advanced or Metastatic Pancreatic Cancer
Status: Active
Location: 9 locations
Biospecimen Resource for Pancreas Research
Status: Active
Location: 3 locations
Pancreas Disease and High-Risk Registry
Status: Active
Location: 3 locations
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
Status: Active
Location: UCHealth University of Colorado Hospital, Aurora, Colorado
Prospective Study to Assess a Diagnostic Aid for Cancer
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Identification of microRNAs in Cachexia in Patients with Pancreatic Cancer
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Northwestern Ovarian Cancer Early Detection and Prevention Program
Status: Active
Location: Northwestern University, Chicago, Illinois
ExoLuminate Study for Early Detection of Pancreatic Cancer
Status: Active
Location: Dana-Farber Cancer Institute, Boston, Massachusetts
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Registry Protocol for the Development of Remote Digital Mobile Physiological Data Collection in Cancer
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Pan-tumor MRD Study
Status: Active
Location: Lancaster General Ann B Barshinger Cancer Institute, Lancaster, Pennsylvania